文献速递冠心病

经导管缘对缘修复术治疗急性心梗后乳头肌断裂二尖瓣反流

[Application of transcatheter edge-to-edge repair in the treatment of papillary muscle rupture of mitral valve after acute myocardial infarction].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2026-01-01

本病例系列纳入2021年12月至2024年10月厦门大学附属心血管病医院12例AMI并发乳头肌断裂及重度二尖瓣反流患者,回顾分析TEER的可行性、早期疗效与安全性。12例均达到手术成功,术后即刻二尖瓣反流均减轻至≤2+,11例存活出院,围术期无器械或手术相关并发症。

要点

  • TEER用于AMI后乳头肌断裂急性重度二尖瓣反流在技术上可行。
  • 12例患者术后即刻二尖瓣反流均减轻至≤2+。
  • 围术期无器械或手术相关并发症,11例存活出院。

核心结论

  • TEER治疗AMI并发乳头肌断裂导致的急性重度二尖瓣反流在技术上具有可行性。
  • TEER能在短期内改善部分高危患者的二尖瓣反流及血流动力学状态。

研究设计与样本

  • 本研究为回顾性病例系列研究。
  • 纳入2021年12月至2024年10月在厦门大学附属心血管病医院接受TEER治疗的12例AMI并发乳头肌断裂及重度二尖瓣反流患者。
  • TEER手术成功定义为二尖瓣前后叶成功抓取并将二尖瓣反流减轻至2+或以下。
  • 术后随访30天评估生存状况及二尖瓣反流程度。

主要发现

  • 患者平均年龄为67.4岁,男性10例。
  • 11例患者诊断为ST段抬高型心肌梗死。
  • 11/12为后内侧乳头肌完全断裂。
  • 10/12的患者出现心原性休克。
  • 12例患者均达到TEER手术成功,术后即刻所有患者二尖瓣反流均减轻至2+或以下。

关键数值与推荐

  • 11/12为后内侧乳头肌完全断裂。
  • 10/12的患者出现心原性休克。
  • 美国胸外科医师学会手术评分中位值为51.9%。
  • 12例患者术后即刻所有患者二尖瓣反流均减轻至2+或以下。
  • 随访30天时,9例患者二尖瓣反流维持≤2+。

临床怎么用

  • 对于AMI并发乳头肌断裂导致急性重度二尖瓣反流的高危患者,可考虑TEER作为治疗选择。

局限性

  • 本研究为小样本回顾性病例系列研究。
  • 结论仍有待更大规模的多中心研究和长期随访证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To preliminarily investigate the clinical feasibility, early efficacy, and safety of transcatheter edge-to-edge repair (TEER) in patients with acute mitral regurgitation caused by papillary muscle rupture complicating acute myocardial infarction (AMI). Methods: The study is a retrospective case series. A retrospective analysis was conducted on clinical data of 12 patients with AMI complicated by papillary muscle rupture and severe mitral regurgitation who underwent TEER at Xiamen Cardiovascular Hospital affiliated to Xiamen University from December 2021 to October 2024. Collected data included demographic characteristics, diagnostics and treatment processes, in-hospital outcomes data. Procedural success of TEER was defined as successful grasping of the anterior and posterior mitral leaflets and reduction of mitral regurgitation to grade 2+or less. Patients were followed up for 30 days post-procedure to evaluate survival status and the severity of mitral regurgitation. Results: The mean age of the patients was 67.4 years, with 10 males. Eleven patients were diagnosed with ST-segment elevation myocardial infarction, and 11 out of 12 cases involved complete rupture of the posteromedial papillary muscle. Cardiogenic shock was present in 10 patients and the median Society of Thoracic Surgeons score was 51.9%. Procedural success was achieved in all 12 patients, with mitral regurgitation reduced to ≤2+immediately post-procedure. Eleven patients survived to discharge, and no device-or procedure-related complications occurred during the perioperative period. During the follow-up period, 2 patients died and 1 was readmitted for acute heart failure. At the 30-day follow-up, 9 patients maintained a mitral regurgitation grade of ≤2+. Conclusions: TEER is technically feasible for treating acute severe mitral regurgitation caused by papillary muscle rupture following AMI. It can effectively reduce mitral regurgitation and improve hemodynamic status in selected high-risk patients in the short term. However, these findings necessitate further validation through larger-scale multicenter studies and long-term follow-up. 目的: 初步探讨经导管二尖瓣缘对缘修复术(TEER)在急性心肌梗死(AMI)并发乳头肌断裂所致急性二尖瓣反流患者中的临床可行性、早期效果及安全性。 方法: 本研究为病例系列研究。回顾性分析2021年12月至2024年10月在厦门大学附属心血管病医院接受TEER治疗的12例AMI并发乳头肌断裂及重度二尖瓣反流患者的临床资料,包括人口学特征、诊疗过程、院内转归。TEER手术成功定义为二尖瓣前后叶成功抓取并将二尖瓣反流减轻至2+或以下。术后随访30 d以评估患者生存状况及二尖瓣反流程度。 结果: 患者的平均年龄为67.4岁,男性10例。11例患者诊断为ST段抬高型心肌梗死,11/12为后内侧乳头肌完全断裂,10/12的患者出现心原性休克,美国胸外科医师学会手术评分中位值为51.9%。12例患者均达TEER手术成功,术后即刻所有患者二尖瓣反流均减轻至2+或以下,11/12的患者存活出院,围术期无器械或手术相关并发症。随访期间2例患者死亡,1例因急性心力衰竭再次住院;随访30 d时,9例患者二尖瓣反流维持≤2+。 结论: TEER治疗AMI并发乳头肌断裂导致的急性重度二尖瓣反流在技术上具有可行性,并能在短期内改善部分高危患者的二尖瓣反流及血流动力学状态。但仍有待更大规模的多中心研究和长期随访证实。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Chen, Lin, Su, et al. [Application of transcatheter edge-to-edge repair in the treatment of papillary muscle rupture of mitral valve after acute myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 41866208. doi:10.3760/cma.j.cn112148-20250128-00076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。